Divarasib (GDC-6036), a covalent KRAS G12C inhibitor, has demonstrated durable clinical responses in a phase 1 study involving patients with advanced or...
2023年9月5日 — Treatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036) led to durable responses with a tolerable safety profile in patients...
An orally available inhibitor of the oncogenic KRAS substitution mutation, G12C, with potential antineoplastic activity. Upon oral administration, divarasib...
... 6036.. 6036. $4.99. Pack of 4. 6036 quantity. Add to cart. Category: Premium Cards. Related products. Front of card has a single pine tree and the words With...
GDC-6036 is an experimental drug being developed for the potential treatment of cancers with particular changes in the genes. An experimental drug is a drug...
After receiving the product, we were very satisfied, got to know your company better, and found that you always adhere to the corporate philosophy of good faith, and we appreciate this attitude.
This manufacturers not only respected our choice and requirements, but also gave us a lot of good suggestions, ultimately, we successfully completed the procurement tasks.
we were very satisfied, got to know your company better, and found that you always adhere to the corporate philosophy of good faith, and we appreciate this attitude.
This company continuously trains its employees, accumulates product production experience, continuously carries out technological innovation, and can really provide customers with excellent products.
Your company has always enjoyed a good reputation in the industry, and you have always taken "integrity" and "pragmatism" as your core culture, and the quality of your products is very good.